The global sustainable packaging market is expected to expand at a CAGR of 8.5% during the forecast period of 2025 to 2033. The market expansion is attributable to the government's stringent laws on sustainable development and the packaging industry's rising need for recycled packaging materials. The production and use of packaging that enhances sustainability are referred to as sustainable packaging.
The global market for monkeypox vaccines and treatments is anticipated to expand at a compound annual growth rate (CAGR) of 11% during the forecast period of 2025 to 2033. The market is anticipated to be driven by factors such as the increasing incidence of monkeypox infection across the globe and the rising demand for treatment and prevention methods. Bavarian Nordic A/S, for example, announced in July 2025 that it had received an additional order for 2.5 million doses of JYNNEOS from the U.S. BARDA.
Despite advances in treatment, the high morbidity and death rate of heart failure is driving the global absorbable antibacterial envelope market. Mortality in individuals with heart failure is not only caused by hemodynamic failure; ventricular arrhythmias might also be to blame. In the coming years, the use of implantable cardioverter defibrillators (ICDs) to reduce arrhythmic sudden fatalities is anticipated to boost the market. Moreover, cardiac resynchronization therapy (CRT) is another promising treatment option for heart failure patients.
The rare kidney disease treatment market is expected to expand at a CAGR of 6% during the forecast period of 2025 to 2033 The global market for rare kidney disease treatment market was valued at US$ 2.5 Bn in 2021. The occurrence of acute renal failure and other kidney illnesses that are relatively uncommon is on the rise dramatically around the world. Rare kidney illnesses have only a limited number of therapeutic options that have been approved.
The global market for rheumatoid arthritis treatments is expected to grow at a CAGR of 5% during the forecast period of 2025 to 2033. Rheumatology is the branch of internal medicine that deals with the diagnosis and treatment of rheumatic illnesses. Rheumatic disorders are characterized by joint, tendon, ligament, bone, and even organ inflammation. These conditions are commonly known as musculoskeletal illnesses and are characterized by significant pain, deformity, and morbidity.
The global market for hyperpigmentation disorder treatment was worth US $4.5 billion in 2021. It is anticipated that the global market will advance at a CAGR of 9% during the forecast period of 2025 to 2033. By the end of 2033, it is estimated that the global market for the treatment of hyperpigmentation disorders would have reached over US $10 billion.
The hazelnut market is expected to expand at a CAGR of 10.2% during the forecast period of 2025 to 2033. It is anticipated that increased awareness regarding the health benefits of consuming hazelnuts would drive enormous demand potential in the global hazelnut market throughout the period forecast from 2020 to 2033.
The water and wastewater treatment market is expected to grow at a CAGR of 7.5% during the forecast period of 2025 to 2033. The global COVID-19 epidemic has been unprecedented and astounding, resulting in a demand for water and wastewater treatment that is lower than anticipated across all regions when compared to levels that existed prior to the pandemic. The growth of the water and wastewater treatment equipment market is likely to be driven during the forecast period by the rising demand for water and wastewater treatment equipment in municipal and industrial applications.
The global market for textile auxiliaries is expected to grow at a CAGR of 5% during the forecast period of 2025 to 2033. Demand for textile auxiliaries is being fuelled across the world by a number of factors, including the expansion of the global apparel and clothing industry, the growing utilisation of textile auxiliaries for a variety of applications, and the shifting emphasis toward environmentally friendly products. By the end of 2025, the global market for textile auxiliaries will account for approximately 40% of the total value of the textile chemicals industry.
In 2020, the global market for insomnia was estimated to be worth US $4.5 billion and is expected to grow at a CAGR of 6.2% during the forecast period of 2025 to 2033. It is anticipated that the strong demand will be fuelled by an increase in the launch of novel products over the course of the forecast period, the availability of a number of generic alternatives, increasing prevalence of insomnia and stressare the key factors that aredriving the growth of insomnia therapies market.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.